News and Trends 20 Dec 2022
iOnctura raises €17.5M for pancreatic cancer therapy
iOnctura BV, a clinical-stage biotech developing novel cancer therapies, has been granted €17.5 million ($18.6 million) funding from the European…
pancreatic cancer
- Latest Posts
News and Trends 1 Nov 2022
Pancreatic cancer could be diagnosed years earlier
Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research from the U.K.…
News and Trends 19 Sep 2022
FDA boosts Antengene pancreatic cancer treatment
Biopharma company Antengene Corporation Limited says ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, has been granted an orphan…
News and Trends 14 Sep 2022
Pancreatic cancer study using dual-cell therapy yields positive results
Australian biotech company Noxopharm Limited has revealed encouraging new preclinical data from its long-term collaboration with UNSW Sydney. The results…
